Novel (±)-trans-β-lactam ureas: Synthesis, in silico and in vitro biological profiling

1A. R. Deshmukh, B. M. Bhawal, D. Krishnaswamy, V. V. Govande, B. A. Shinkre and A. Jayanthi, Azetidin-2-ones, synthon for biologically important compounds, Curr. Med. Chem. 11(14) (2004) 1889–1920; https://doi.org/10.2174/0929867043364874Search in Google Scholar

2M. Bortolami, I. Chiarotto, L. Mattiello, R. Petrucci, D. Rocco, F. Vetica and M. Feroci, Organic electrochemistry: Synthesis and functionalization of b-lactams in the twenty-first century, Heterocycl. Commun. 27(1) (2021) 32–44; https://doi.org/10.1515/hc-2020-0121Search in Google Scholar

3K. Poole, Resistance to b-lactam antibiotics, Cell. Mol. Life Sci. 61 (2004) 2200–2223; https://doi.org/10.1007/s00018-004-4060-9Search in Google Scholar

4S. Y. Essack, The development of b-lactam antibiotics in response to the evolution of b-lactamases, Pharm. Res. 18 (2001) 1391–1399; https://doi.org/10.1023/A:1012272403776Search in Google Scholar

5D. M. Livermore and J. D. Williams, b-lactams: Mode of Action and Mechanisms of Bacterial Resistance, in Antibiotics in Laboratory Medicine (Ed. V. Lorian), 4th ed., Williams and Wilkins, Baltimore 1996, pp. 502–577.Search in Google Scholar

6C. Palomo, J. M. Aizpurua, I. Ganboa and M. Oiarbide, b-lactams as versatile intermediates in α- and b-amino acid synthesis, Synlett. 12 (2001) 1813–1826; https://doi.org/10.1055/s-2001-18733Search in Google Scholar

7B. Alcaide, P. Almendros and C. Aragoncillo, b-lactams: versatile building blocks for the stereo-selective synthesis of non-b-lactam products, Chem. Rev. 107(11) (2007) 4437–4492; https://doi.org/10.1021/cr0307300Search in Google Scholar

8A. K. Halve, D. Bhadauria and R. Dubey, N/C-4 substituted azetidin-2-ones: synthesis and preliminary evaluation as new class of antimicrobial agents, Bioorg. Med. Chem. Lett. 17(2) (2007) 341–345; https://doi.org/10.1016/j.bmcl.2006.10.064Search in Google Scholar

9B. Hamad, The antibiotics market, Nat. Rev. Drug Discov. 9 (2010) 675–676; https://doi.org/10.1038/nrd3267Search in Google Scholar

10S. Zavar, M. Zarei and M. Saraei, Synthesis of b-lactams via Staudinger reaction using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline as a carboxylic acid activator, Synth. Commun. 46(24) (2016) 2031–2036; https://doi.org/10.1080/00397911.2016.1244691Search in Google Scholar

11A. Kamath and I. Ojima, Advances in the chemistry of b-lactam and its medicinal applications, Tetrahedron 68(52) (2012) 10640–10664; https://doi.org/10.1016/j.tet.2012.07.090Search in Google Scholar

12P. D. Mehta, N. P. S. Sengar and A. K. Pathak, 2-Azetidinone – a new profile of various pharmacological activities, Eur. J. Med. Chem. 45(12) (2010) 5541–5560; https://doi.org/10.1016/j.ejmech.2010.09.035Search in Google Scholar

13A. Jarrahpour, P. Shirvani, V. Sinou, C. Latour and J. M. Brunel, Synthesis and biological evaluation of some new b-lactam-triazole hybrids, Med. Chem. Res. 25 (2016) 149–162; https://doi.org/10.1007/s00044-015-1474-xSearch in Google Scholar

14A. Jarrahpour, P. Shirvani, V. Sinou, C. Latour and J. M. Brunel, Diastereoselective synthesis of potent antimalarial cis-b-lactam agents through a [2+2] cycloaddition of chiral imines with a chiral ketene, Eur. J. Med. Chem. 87 (2014) 364–371; http://dx.doi.org/10.1016/j.ejmech.2014.09.077Search in Google Scholar

15D. A. Burnett, b-lactam cholesterol absorption inhibitors. b-lactam cholesterol absorption inhibitors, Curr. Med. Chem. 11(14) (2004) 1873–1887; https://doi.org/10.2174/0929867043364865Search in Google Scholar

16J. C. Sutton, S. A. Bolton, K. S. Hartl, M.-H. Huang, G. Jacobs, W. Meng, M. Ogletree, Z. Pi, W. A. Schumacher, S. M. Seiler, W. A. Slusarchyk, U. Treuner, R. Zahler, G. Zhao and G. S. Bisacchi, Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors, Bioorg. Med. Chem. Lett. 12(21) (2002) 3229–3233; https://doi.org/10.1016/S0960-894X(02)00688-1Search in Google Scholar

17A. D. Borthwick, G. Weingarten, T. M. Haley, M. Tomaszewski, W. Wang, Z. Hu, J. Bedard, H. Jin, L. Yuen and T. S. Mansour, Design and synthesis of monocyclic b-lactams as mechanism-based inhibitors of human cytomegalovirus protease, Bioorg. Med. Chem. Lett. 8(4) (2008) 365–370; https://doi.org/10.1016/s0960-894x(98)00032-8Search in Google Scholar

18C. D. Guillon, G. A. Koppel, M. J. Brownstein, M. O. Chaney, C. F. Ferris, S.-f. Lu, K. M. Fabio, M. J. Miller, N. D. Heindel, D. C. Hunden, R. D. G. Cooper, S. W. Kaldor, J. J. Skelton, B. A. Dressman, M. P. Clay, M. I. Steinberg, R. F. Bruns and N. G. Simon, Azetidinones as vasopressin V1a antagonists, Bioorg. Med. Chem. 15(5) (2007) 2054–2080; https://doi.org/10.1016/j.bmc.2006.12.031Search in Google Scholar

19N. M. O’Boyle, M. Carr, L. M. Greene, O. Bergin, S. M. Nathwani, T. McCabe, D. G. Lloyd, D. M. Zisterer and M. J. Meegan, Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents, J. Med. Chem. 53(24) (2010) 8569–8584; https://doi.org/10.1021/jm101115uSearch in Google Scholar

20B. K. Banik, I. Banik and F. F. Becker, Asymmetric synthesis of anticancer b-lactams via Staudinger reaction: utilization of chiral ketene from carbohydrate, Eur. J. Med. Chem. 45(2) (2010) 846–848; https://doi.org/10.1016/j.ejmech.2009.11.024Search in Google Scholar

21R. Sharma, P. Samadhiya, S. D. Srivastava and S. K. Srivastava, Synthesis and biological activity of new series of N-[3-(1H-1,2,3- benzotriazol-1-yl)propyl]-2-(substituted phenyl)-3-chloro-4-oxo-1-azetidinecarboxamide, Acta Chim. Slov. 58(1) (2011) 110–119.Search in Google Scholar

22T. Sperka, J. Pitlik, P. Bagossi and J. Tözsér, Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease, Bioorg. Med. Chem. Lett. 15(12) (2005) 3086–3090; https://doi.org/10.1016/j.bmcl.2005.04.020Search in Google Scholar

23C. Saturnino, B. Fusco, P. Saturnino, G. D. E. Martino, F. Rocco and J.-C. Lancelot, Evaluation of analgesic and anti-inflammatory activity of novel beta-lactam monocyclic compounds, Biol. Pharm. Bull. 23(5) (2000) 654–656; https://doi.org/10.1248/bpb.23.654Search in Google Scholar

24R. K. Goel, M. P. Mahajan and S. K. Kulkarni, Evaluation of anti-hyperglycemic activity of some novel monocyclic b-lactams, J. Pharm. Pharm. Sci. 7(1) (2004) 80–83.Search in Google Scholar

25A. Jarrahpour, E. Ebrahimi, R. Khalifeh, H. Sharghi, M. Sahraei, V. Sinou, C. Latour and J. M. Brunel, Synthesis of novel b-lactams bearing an anthraquinone moiety, and evaluation of their antimalarial activities, Tetrahedron 68(24) (2012) 4740–4744; https://doi.org/10.1016/j.tet.2012.04.011Search in Google Scholar

26S. Hosseyni and A. Jarrahpour, Recent advances in b-lactam synthesis, Org. Biomol. Chem. 16 (2018) 6840–6852; https://doi.org/10.1039/C8OB01833BSearch in Google Scholar

27C. R. Pitts and T. Lectka, Chemical synthesis of b-lactams: Asymmetric catalysis and other recent advances, Chem. Rev. 114(16) (2014) 7930–7953; https://doi.org/10.1021/cr4005549Search in Google Scholar

28S. Deketelaere, T. Van Nguyen, C. V. Stevens and M. D’hooghe, Synthetic approaches toward monocyclic 3-amino-b-lactams, ChemistryOpen 6(3) (2017) 301–319; https://doi.org/10.1002/open.201700051Search in Google Scholar

29N. Payili, S. Yennam, S. R. Rekula, C. G. Naidu, Y. Bobde and B. Ghoshc, Design, synthesis, and evaluation of the anticancer properties of novel quinone bearing carbamyl b-lactam hybrids, J. Heterocyclic Chem. 55(6) (2018) 1358–1365; https://doi.org/10.1002/jhet.3169Search in Google Scholar

30L. Jiao, Y. Liang and J. Xu, Origin of the relative stereoselectivity of the b-lactam formation in the Staudinger reaction, J. Am. Chem. Soc. 128(18) (2006) 6060–6069; https://doi.org/10.1021/ja056711kSearch in Google Scholar

31F. P. Cossío, A. de Cózar, S. M. Sierra, L. Casarrubios, J. G. Muntaner, B. K. Banik and D. Bandyopadhyay, Role of imine isomerization in the stereocontrol of the Staudinger reaction between ketenes and imines, RSC Adv. 12 (2021) 104–117; https://doi.org/10.1039/d1ra06114cSearch in Google Scholar

32T. C. Malig, D. Yu and J. E. Hein, A revised mechanism for the Kinugasa reaction, J. Am. Chem. Soc. 140(29) (2018) 9167–9173; https://doi.org/10.1021/jacs.8b04635Search in Google Scholar

33F. Toda, H. Miyamoto, M. Inoue, S. Yasaka and I. Matijasic, Enantioselective photocyclization of amides to beta-lactam derivatives in inclusion crystals with an optically active host, J. Org. Chem. 65(9) (2000) 2728–2732; https://doi.org/10.1021/jo991832mSearch in Google Scholar

34Z. Wang, J. Ni, Y. Kuninobu and M. Kanai, Copper-catalyzed intramolecular C(sp³)H and C(sp²) H amidation by oxidative cyclization, Angew. Chem. Int. Ed. 53(13) (2014) 3496–3499; https://doi.org/10.1002/anie.201311105Search in Google Scholar

35S. France, A. Weatherwax, A. E. Taggi and T. Lectka, Advances in the catalytic, asymmetric synthesis of b-lactams, Acc. Chem. Res. 37(8) (2004) 592–600; https://doi.org/10.1021/ar030055gSearch in Google Scholar

36T. Dražić, M. Roje, M. Jurin and G. Pescitelli, Synthesis, separation and absolute configuration determination by ECD Spectroscopy and TDDFT calculations of 3-amino-b-lactams and derived guanidines, Eur. J. Org. Chem. 2016(24) (2016) 4189–4199; https://doi.org/10.1002/ejoc.201600641Search in Google Scholar

37Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 11th ed., CLSI standard M07, CLSI, Wayne (PA, USA) 2018; https://clsi.org/media/1928/m07ed11_sample.pdf; last access date April 6, 2020Search in Google Scholar

38J. M. Andrews, Determination of minimum inhibitory concentrations, J. Antimicrob. Chemother. 48(Suppl. S1) (2001) 5–16; https://doi.org/10.1093/JAC/48.SUPPL_1.5Search in Google Scholar

39Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 3^rd ed., CLSI standard M38, CLSI, Wayne (PA, USA) 2017; https://clsi.org/media/1894/m38ed3_sample.pdf; last access date April 27, 2020Search in Google Scholar

40M. Hranjec, M. Kralj, I. Piantanida, M. Sedić, L. Šuman, K. Pavelić and G. Karminski-Zamola, Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolines. synthesis, photochemical synthesis, DNA binding and antitumor evaluation, Part 3, J. Med. Chem. 50(23) (2007) 5696–5711; https://doi.org/10.1021/jm070876hSearch in Google Scholar

41M. Hranjec, I. Piantanida, M. Kralj, L. Šuman, K. Pavelić and G. Karminski-Zamola, Novel amid-ino-substituted thienyl- and furylvinyl-benzimidazole derivatives and their photochemical conversion into corresponding diaza-cyclopenta[c]fluorenes. Synthesis, interactions with DNA and RNA and antitumor evaluation, J. Med. Chem. 51(16) (2008) 4899–4910; https://doi.org/10.1021/jm8000423Search in Google Scholar

42M. R. Boyd and K. D. Paull, Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen, Drug Dev. Res. 34(2) (1995) 91–109; https://doi.org/10.1002/ddr.430340203Search in Google Scholar

43M. S. Lowless, M. Waldman, R. Franczkiewicz and R. D. Clark, Using Chemoinformatics in Drug Discovery, in New Approaches to Drug Discovery, Handbook of Experimental Pharmacology (Eds. U. Nielsch, U. Fuhrmann and S. Jaroch), Vol. 232, Springer Int. Publ. Switzerland, Cham 2016, pp. 232, 139–170.Search in Google Scholar

44H. Yang, C. Lou, L. Sun, J. Li, Y. Cai, Z. Wang, W. Li, G. Liu and Y. Tang, admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties, Bioinformatics 35(6) (2019) 1067–1069; https://doi.org/10.1093/bioinformatics/bty707Search in Google Scholar

45D. A. Filimonov and V. V. Poroikov, Probabilistic Approach in Activity Prediction, in Chemoinformatics Approaches to Virtual Screening (Eds. A. Varnek and A. Tropsha), RSC Publishing, Cambridge (UK) 2008, pp. 182–216.Search in Google Scholar

46A. Daina, O. Michielin and V. Zoete, SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Res. 47(W1) (2019) W357– W364; https://doi.org/10.1093/nar/gkz382Search in Google Scholar

47D. Bandyopadhyay, J. Cruz and B. K. Banik, Novel synthesis of 3-pyrrole substituted b-lactams via microwave-induced bismuth nitrate-catalyzed reaction, Tetrahedron 68(52) (2012) 10686–10695; https://doi.org/10.1016/j.tet.2012.06.009Search in Google Scholar

48K. Radolović, I. Habuš and B. Kralj, New thiazolidinone and triazinethione conjugates derived from amino-b-lactams, Heterocycles 78(7) (2009) 1729–1759; https://doi.org/10.3987/COM-09-11668Search in Google Scholar

49C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 23(1–3) (1997) 3–25; https//doi.org/10.1016/S0169-409X(96)00423-1Search in Google Scholar

50C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 64(Suppl.) (2012) 4–17; https://doi.org/10.1016/j.addr.2012.09.019Search in Google Scholar

51C. A. Lipinski, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Method 44(1) (2000) 235–249; https//doi.org/10.1016/s1056-8719(00)00107-6Search in Google Scholar

52D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward and K. D. Kopple, Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem. 45(12) (2002) 2615–2623; https://doi.org/10.1021/jm020017nSearch in Google Scholar

53S. Lobo, Is there enough focus on lipophilicity in drug discovery?, Expert Opin. Drug Discov. 15(3) (2019) 261–263; https://doi.org/10.1080/17460441.2020.1691995Search in Google Scholar

54R. Haddad-Tóvolli, N. R. V. Dragano, A. F. S. Ramalho and L. A. Velloso, Development and function of the blood-brain barrier in the context of metabolic control, Front. Neurosci. 11 (2017) Article ID 224 (12 pages); https://www.frontiersin.org/articles/10.3389/fnins.2017.00224Search in Google Scholar

55E. Stavropoulou, G. G. Pircalabioru and E. Bezirtzoglou, The role of cytochromes P450 in infection, Front. Immunol. 9 (2018) Article ID 89 (7 pages); https://doi.org/10.3389/fimmu.2018.00089Search in Google Scholar

56A. M. McDonnell and C. H. Dang, Basic review of the cytochrome p450 system, J. Adv. Pract. Oncol. 4 (2013) 263–268; https://doi.org/10.6004/jadpro.2013.4.4.7Search in Google Scholar

57F. P. Guengerich, Cytochrome P450 and chemical toxicology, Chem. Res. Toxicol. 21(1) (2008) 70–83; https://doi.org/10.1021/tx700079zSearch in Google Scholar

58B. Testa, A. Pedretti and G. Vistoli, Reactions and enzymes in the metabolism of drugs and other xenobiotics, Drug Discov. Today 17(11–12) (2012) 549–560; https://doi.org/10.1016/j.drudis.2012.01.017Search in Google Scholar

59A. F. El-Kattan and M. V. S. Varma, Navigating transporter sciences in pharmacokinetics characterization using the extended clearance classification system, Drug. Metab. Dispos. 46(5) (2018) 729–739; https://doi.org/10.1124/dmd.117.080044Search in Google Scholar

60M. V. Varma, S. J. Steyn, C. Allerton and A. F. El-Kattan, Predicting clearance mechanism in drug discovery: Extended clearance classification system (ECCS), Pharm. Res. 32 (2015) 3785–3802; https://doi.org/10.1007/s11095-015-1749-4Search in Google Scholar